"White dot syndromes", an inappropriate and outdated misnomer

Int Ophthalmol. 2022 Jan;42(1):1-6. doi: 10.1007/s10792-021-02121-4.

Piergiorgio Neri^#^{1

2

3}, Carl P Herbort Jr^#⁴, Alireza Hedayatfar^#^{5

6}, Ilknur Tugal-Tutkun⁷, Luca Cimino⁸, Cristhian A Urzua^{9

10

11}, Ioannis Papasavvas⁴, Masuru Takeuchi¹², Vania Lages¹³

¹ The Eye Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, P.O. Box 112412, Abu Dhabi, United Arab Emirates. nerip@clevelandclinicabudhabi.ae.
² Cleveland Clinic Lerner College of Medicine, Case Western University, Cleveland, OH, USA. nerip@clevelandclinicabudhabi.ae.
³ Khalifa University, Abu Dhabi, United Arab Emirates. nerip@clevelandclinicabudhabi.ae.
⁴ Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialised Care (COS), Lausanne, Switzerland.
⁵ Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
⁶ Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.
⁷ Department of Ophthalmology, University of Istanbul, Istanbul, Turkey.
⁸ Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
⁹ Laboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile.
¹⁰ Department of Ophthalmology, University of Chile, Santiago, Chile.
¹¹ Facultad de Medicina, Clinica Alemana-Universidad del Desarrollo, Santiago, Chile.
¹² Department of Ophthalmology, National Defence Medical College, Tokorozawa, Saitama, Japan.
¹³ Hospital Nossa Senhora da Oliveira, Guimarães, Portugal.

^# Contributed equally.

No abstract available

Publication types